Table II.
Univariate and multivariate analysis for overall survival in GBC patients.
| Variables | Univariate analysis
|
Multivariate analysis
|
||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Sex (male/female) | 1.006 (0.341–2.967) | 0.991 | ||
| Age (<60/≥60) | 1.062 (0.392–2.879) | 0.906 | ||
| Histology (well + moderate/poor) | 0.801 (0.187–3.427) | 0.765 | ||
| T (Tis + T1 + T2/T3 + T4) | 2.833 (1.088–7.379) | 0.033 | 1.217 (0.396–3.743) | 0.732 |
| N (absent/present) | 2.286 (0.968–5.402) | 0.059 | ||
| M (negative/positive) | 4.012 (1.410–11.411) | 0.009 | 2.413 (0.823–7.078) | 0.109 |
| Tumor stage (0–I/II–IV) | 4.353 (0.584–32.453) | 0.151 | ||
| BRD4 expression (low/high) | 5.474 (1.740–17.215) | 0.004 | 4.336 (1.173–16.027) | 0.028 |
HR, hazard ratio; CI, confidence interval.